Cargando…
An innovative method of nonclinical efficacy and toxicological evaluation of recombinant Salmonella typhi Ty21a expressing HPV16 and 18 L1 proteins
Advancement in technology led to development of live attenuated Salmonella typhi Ty21a as enteric vector for expression of foreign proteins. Such vector platform is inevitable for development of vaccine candidate against human papilloma virus (HPV), the etiological agent of cervical cancer with high...
Autores principales: | Srinivasa Reddy, Yathapu, Narendra Babu, K., Qadri, S.S.Y.H., Surekha, M.V., Dinesh Kumar, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374194/ https://www.ncbi.nlm.nih.gov/pubmed/34434742 http://dx.doi.org/10.1016/j.mex.2021.101219 |
Ejemplares similares
-
Toxicological data of rats and rabbits: Sub-chronic testing of recombinant HPV vaccine through oral and intranasal routes
por: Srinivasa Reddy, Y., et al.
Publicado: (2021) -
Genome Sequence of Salmonella enterica Serovar Typhi Oral Vaccine Strain Ty21a
por: Xu, DeQi, et al.
Publicado: (2013) -
Nonspecific effects of oral vaccination with live-attenuated Salmonella Typhi strain Ty21a
por: Pennington, S. H., et al.
Publicado: (2019) -
Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery
por: Dharmasena, Madushini N., et al.
Publicado: (2016) -
Longevity of duodenal and peripheral T-cell and humoral responses to live-attenuated Salmonella Typhi strain Ty21a
por: Pennington, Shaun H., et al.
Publicado: (2018)